eFFECTOR Therapeutics, Inc. (EFTR) vs TFF Pharmaceuticals, Inc. (TFFP)

eFFECTOR Therapeutics, Inc. and TFF Pharmaceuticals, Inc. are both Biotechnology companies. TFF Pharmaceuticals, Inc. is the larger, with a market value of $290.0K against $200.0K — 1.4× the size. TFF Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 24.5% against −86.2%. eFFECTOR Therapeutics, Inc. has the higher net margin (0.00% vs −1,595.0%) and the higher return on invested capital (0.00% vs −2,202.8%). Across the 16 metrics below, eFFECTOR Therapeutics, Inc. leads on 10 and TFF Pharmaceuticals, Inc. on 6.

Valuation

Metric EFTR TFFP Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.26 11.47
P/B n/m 0.10 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.20 0.13 0.74
EV/Sales (1.67) (1.98) 10.73
Earnings yield 0.00% (9,200.00%) (28.84%)
Free cash flow yield 0.00% (4,190.74%) (23.03%)

Profitability

Metric EFTR TFFP Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,610.76%) 0.00%
Net margin 0.00% (1,595.04%) 0.00%
Free cash flow margin 0.00% (1,084.30%) 0.00%
Return on equity 1,737.63% (220.13%) (57.72%)
Return on assets (141.18%) (168.66%) (49.22%)
Return on invested capital 0.00% (2,202.77%) 0.00%

Growth

Metric EFTR TFFP Biotechnology median
Revenue growth (TTM) (86.21%) 24.54% 5.64%
EPS growth (last fiscal year) (19.05%) 55.27% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EFTR TFFP Biotechnology median
Debt to equity 22.87 0.00 0.00
Current ratio 1.03 0.89 4.73
Net debt to EBITDA (0.03) 0.26 0.96

Dividend

Metric EFTR TFFP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EFTR TFFP Biotechnology median
Market cap 200.00k 290.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack